Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

Senseonics Holdings, Inc. (NYSE American: SENS) ("Senseonics" or the "Company"), a medical technology company focused on the ...

In recent years, digital health has become a new development trend in the global health and medical industry. By using ...

Biosensors that measure glucose are now available without a prescription. Wearing one nearly burst my wellness bubble.

If you hear the phrase “bionic pancreas,” you might flash back to those 1970s sci-fi TV shows. You may picture a cartoon ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A ...

Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...

Ascensia Diabetes Care announced today that it launched the Eversense 365 CGM system from Senseonics (NYSE:SENS) ...

Millions of UK residents have received a warning amid concerns about the underreporting of issues with a much used medical ...

Trinity Biotech plc TRIB has completed its first pre-pivotal clinical trial in Europe for its next-generation continuous glucose monitor (CGM). This trial assessed the effectiveness of significant ...

Millions have been alerted over concerns that not enough issues with a medical device are being reported. In the UK, over 5.6 ...